Jianchang Lin

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Statistics in medicine

Journal of biopharmaceutical statistics

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine 43 (12) (2024)
Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine (2024)
Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine 43 (12) (2024)
Wei Wei, Ondrej Blaha, Denise A Esserman, Daniel Zelterman, Michael J Kane, Rachael Liu, Jianchang Lin
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in medicine 43 (12) (2024)
Xin Li, Godwin Yung, Jianchang Lin, Jian Zhu
Estimation of conditional power in the presence of auxiliary data. Statistics in medicine (2023)
Dehua Bi, Meizi Liu, Jianchang Lin, Rachael Liu
BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints. Statistics in medicine (2023)
Wanying Ma, Mengya Liu, Jian Zhu, Qing Li, Elaine Hoffman, Jianchang Lin
Semiparametric pseudo-score and pseudo-likelihood for evaluating correlate of protection in vaccine trials. Statistics in medicine (2023)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric Churchill, Minal Mehta, Danny Nguyen
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer. Expert review of anticancer therapy (2022)
Jane Pan, Veronica Bunn, Bradley Hupf, Jianchang Lin
Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analyses. Journal of biopharmaceutical statistics 32 (4) (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric N Churchill, Minal Mehta, Danny Nguyen
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer. Expert review of anticancer therapy 23 (1) (2022)
Tian He, Rachael Liu, Meizi Liu, Jianchang Lin
PMED: Optimal Bayesian Platform Trial Design with Multiple Endpoints. Journal of biopharmaceutical statistics 32 (4) (2022)
Ziyu Ji, Junjing Lin, Jianchang Lin
Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing. Journal of biopharmaceutical statistics 32 (4) (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric Churchill, Minal Mehta, Danny Nguyen
Expert review of anticancer therapy (2022)
Zihan Lin, Dan Zhao, Junjing Lin, Ai Ni, Jianchang Lin
Statistical methods of indirect comparison with real-world data for survival endpoint under non-proportional hazards. Journal of biopharmaceutical statistics 32 (4) (2022)
Chengxue Zhong, Qing Li, Liwen Wu, Jianchang Lin
Using surrogate information to improve confirmatory platform trial with sample size re-estimation. Journal of biopharmaceutical statistics 32 (4) (2022)
James Chih-Hsin Yang, Caicun Zhou, Pasi A Jänne, Suresh S Ramalingam, Tae Min Kim, Gregory J Riely, Alexander I Spira, Zofia Piotrowska, Tarek Mekhail, Maria Rosario Garcia Campelo, Enriqueta Felip, Lyudmila Bazhenova, Shu Jin, Manmit Kaur, Paul M Diderichsen, Neeraj Gupta, Veronica Bunn, Jianchang Lin, Eric N Churchill, Minal Mehta, Danny Nguyen
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer. Expert review of anticancer therapy 23 (1) (2022)
Bradley Hupf, Veronica Bunn, Jianchang Lin, Cheng Dong
Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials. Statistics in medicine 40 (14) (2021)
Meizi Liu, Veronica Bunn, Bradley Hupf, Junjing Lin, Jianchang Lin
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data. Statistics in medicine 40 (22) (2021)
Junjing Lin, Jianchang Lin
Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies. Journal of biopharmaceutical statistics (2021)
Pin Li, Rachael Liu, Jianchang Lin, Yuan Ji
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacy. Journal of biopharmaceutical statistics 30 (6) (2020)
Mo Li, Rachael Liu, Jianchang Lin, Veronica Bunn, Hongyu Zhao
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strata. Journal of biopharmaceutical statistics 30 (5) (2020)
Arup K Sinha, Lemuel Moye, Linda B Piller, Jose-Miguel Yamal, Carlos H Barcenas, Jianchang Lin, Barry R Davis
Adaptive group-sequential design with population enrichment in phase 3 randomized controlled trials with two binary co-primary endpoints. Statistics in medicine 38 (21) (2019)